{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:16:14Z","timestamp":1762542974149},"reference-count":42,"publisher":"Hogrefe Publishing Group","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2018,12]]},"abstract":" Zusammenfassung. Folienrauchen bezeichnet einen inhalativen Konsum von Heroin. Nach Erhitzung und Verfl\u00fcssigung des Heroins durch Anwendung eines Feuerzeugs auf der Unterseite einer Aluminiumfolie wird mittels Strohhalm der dadurch entstehende Rauch inhaliert. Neben dem bekannten intraven\u00f6sen (IV) Konsum ist das Folienrauchen die zweith\u00e4ufigste Form des Heroinkonsums. Die Wirkung tritt im Vergleich zum IV-Konsum mit wenigen Minuten Verz\u00f6gerung ein. Die beim IV-Konsum beobachteten \u00fcbertragbaren Krankheiten wie HIV, Hepatitis oder andere Infektionen werden beim inhalativem Konsum nicht berichtet. Es kann jedoch zum Auftreten von schweren Bronchospasmen kommen. Eine zerebrale Auswirkung ist die Leukoenzephalopathie, eine spongiforme Degeneration der weissen Hirnsubstanz, die bisher nur beim inhalativen Heroinkonsum beschrieben wurde. Urs\u00e4chlich soll die Pyrolysat-Bildung beim Erhitzungsprozess von Heroin beteiligt sein. Bei h\u00e4ufig beobachteter Polytoxikomanie und gleichzeitigem Tabakkonsum ist die Kausalit\u00e4t von Konsumfolgen generell schwierig zu beurteilen. Bei Auftreten einer unklaren pulmonalen Symptomatik oder Erkrankung, die sich wie ein schwerer Asthmaanfall manifestiert, sollte differenzialdiagnostisch an den inhalativen Heroinkonsum gedacht werden. <\/jats:p>","DOI":"10.1024\/1661-8157\/a003128","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T08:30:33Z","timestamp":1544517033000},"page":"1393-1398","source":"Crossref","is-referenced-by-count":2,"title":["Folienrauchen\/Heroin inhalativ"],"prefix":"10.1024","volume":"107","author":[{"given":"Ayla","family":"Yalamanoglu","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Pneumologie und Klinik und Poliklinik f\u00fcr Innere Medizin, Universit\u00e4tsspital Z\u00fcrich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mac\u00e9 M.","family":"Schuurmans","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pneumologie und Klinik und Poliklinik f\u00fcr Innere Medizin, Universit\u00e4tsspital Z\u00fcrich"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","reference":[{"key":"c1","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2018. United Nations publication, Sales No. E.18.XI.9. 2018. https:\/\/www.unodc.org\/wdr2018\/; letzter Zugriff: 25.09.2018."},{"key":"c2","doi-asserted-by":"crossref","unstructured":"Nordt C, Stohler R: Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 2006; 367: 1830\u20131834.","DOI":"10.1016\/S0140-6736(06)68804-1"},{"key":"c3","doi-asserted-by":"crossref","unstructured":"Nordt C, Landolt K, Stohler R: Estimating incidence trends in regular heroin use in 26 regions of Switzerland using methadone treatment data. Subst Abuse Treat Prev Policy 2009; 4: 14.","DOI":"10.1186\/1747-597X-4-14"},{"key":"c4","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: European Drug Report. Trends and Development. 2018. http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/8585\/20181816_TDAT18001ENN_PDF.pdf; letzter Zugriff: 25.09.2018."},{"key":"c5","doi-asserted-by":"crossref","unstructured":"Kramer T.H, et al.: Chasing the dragon: the smoking of heroin and cocaine. J Subst Abuse Treat 1990; 7: 65.","DOI":"10.1016\/0740-5472(90)90039-S"},{"key":"c6","doi-asserted-by":"crossref","unstructured":"Strang, J, Griffiths P, Gossop M: Heroin smoking by \u2019chasing the dragon\u2019: origins and history. Addiction 1997; 92: 673\u2013683; discussion 685\u2013695.","DOI":"10.1111\/j.1360-0443.1997.tb02927.x"},{"key":"c7","doi-asserted-by":"crossref","unstructured":"Gossop, M, Griffiths P, Strang J: Chasing the dragon: characteristics of heroin chasers. Br J Addict 1988; 83: 1159\u20131162.","DOI":"10.1111\/j.1360-0443.1988.tb03022.x"},{"key":"c8","unstructured":"Drogeninfo Folienrauchen. Innsbruck, \u00d6sterreich; Kontakt+co Suchtpr\u00e4vention Jugendrotrkeuz: 2016. https:\/\/www.kontaktco.at\/shop\/pdf\/102-16.pdf; letzter Zugriff: 30.10.2018."},{"key":"c9","doi-asserted-by":"crossref","unstructured":"Brenneisen R, Hasler F: GC\/MS determination of pyrolysis products from diacetylmorphine and adulterants of street heroin samples. J Forensic Sci 2002; 47: 885\u2013888.","DOI":"10.1520\/JFS15456J"},{"key":"c10","doi-asserted-by":"crossref","unstructured":"Huizer H: Analytical studies on illicit heroin. V. Efficacy of volatilization during heroin smoking. Pharm Weekbl Sci 1987; 9: 203\u2013211.","DOI":"10.1007\/BF02029331"},{"key":"c11","unstructured":"Cook, C.E, Jeffcoat A.R: Pyrolytic degradation of heroin, phencyclidine, and cocaine: identification of products and some observations on their metabolism. NIDA Res Monogr 1990; 99: 97\u2013120."},{"key":"c12","unstructured":"Infos: F.S.U. Folie rauchen. Berlin; fixpunkt: 2013. http:\/\/www.fixpunkt-berlin.de\/fileadmin\/user_upload\/PDF\/Infomaterial\/SaferUse\/10-Folie_rauchen_2013.pdf; letzer Zugriff: 25.09.2018."},{"key":"c13","unstructured":"Integrative Drogenhilfe: Folie rauchen. Frankfurt\/M.; ihd. https:\/\/www.idh-frankfurt.de\/images\/downloads\/folie_rauchen.pdf; letzter Zugriff: 25.09.2018."},{"key":"c14","unstructured":"Drugscouts: Heroin. Drugscouts, Leipzig: 2008. https:\/\/drugscouts.de\/de\/lexikon\/heroin; letzer Zugriff: 25.09.2018."},{"key":"c15","unstructured":"PsychoaktiveSubstanzen.de: Heroin \u2013 Ber\u00fcchtigtes hochpotentes Opiod & Strassendroge mit enormer Suchtgefahr (Substanzinfo). 2017. http:\/\/psychoaktivesubstanzen.de\/heroin; letzter Zugriff: 25.09.2018."},{"key":"c16","unstructured":"Bluelight: Difference between heroin #3 and 4; http:\/\/www.bluelight.org\/vb\/threads\/632890-Difference-between-heroin-3-and-4; letzter Zugriff: 25.09.2018."},{"key":"c17","doi-asserted-by":"crossref","unstructured":"Rook EJ, et al.: Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol 2006; 1: 109\u2013118.","DOI":"10.2174\/157488406775268219"},{"key":"c18","doi-asserted-by":"crossref","unstructured":"Hendriks VM, et al.: Heroin self-administration by means of \u2019chasing the dragon\u2019: pharmacodynamics and bioavailability of inhaled heroin. Eur Neuropsychopharmacol 2001; 11: 241\u2013252.","DOI":"10.1016\/S0924-977X(01)00091-8"},{"key":"c19","doi-asserted-by":"crossref","unstructured":"White JM, Irvine RJ: Mechanisms of fatal opioid overdose. Addiction 1999; 94: 961\u2013972.","DOI":"10.1046\/j.1360-0443.1999.9479612.x"},{"key":"c20","doi-asserted-by":"crossref","unstructured":"Griffiths P, et al.: Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction 1994; 89: 301\u2013309.","DOI":"10.1111\/j.1360-0443.1994.tb00896.x"},{"key":"c21","doi-asserted-by":"crossref","unstructured":"Schwartz RH: Adolescent heroin use: a review. Pediatrics 1998; 102: 1461\u20131466.","DOI":"10.1542\/peds.102.6.1461"},{"key":"c22","unstructured":"Bazoukis G, et al.: Non-cardiogenic pulmonary edema, rhabdomyolysis and myocardial injury following heroin inhalation: a case report. Hippokratia, 2016; 20: 84\u201387."},{"key":"c23","doi-asserted-by":"crossref","unstructured":"Sporer KA, Dorn E: Heroin-related noncardiogenic pulmonary edema: a case series. Chest 200; 120: 1628\u20131632.","DOI":"10.1378\/chest.120.5.1628"},{"key":"c24","doi-asserted-by":"crossref","unstructured":"Gotway MB, et al.: Thoracic complications of illicit drug use: an organ system approach. Radiographics 2002; 22: 119\u2013135.","DOI":"10.1148\/radiographics.22.suppl_1.g02oc01s119"},{"key":"c25","doi-asserted-by":"crossref","unstructured":"Eyupoglu, D, et al.: Acute eosinophilic pneumonia secondary to heroin inhalation. Tuberk Toraks 2017; 65: 154\u2013156.","DOI":"10.5578\/tt.10438"},{"key":"c26","doi-asserted-by":"crossref","unstructured":"Tsapas A, et al.: Eosinophilic pneumonia associated with heroin inhalation: a case report. Wien Klin Wochenschr, 2008; 120: 178\u201380.","DOI":"10.1007\/s00508-008-0938-0"},{"key":"c27","doi-asserted-by":"crossref","unstructured":"Kissner DG, et al.: Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis 1987; 136: 1250\u20131252.","DOI":"10.1164\/ajrccm\/136.5.1250"},{"key":"c28","doi-asserted-by":"crossref","unstructured":"Hughes, S, Calverley PM: Heroin inhalation and asthma. BMJ, 1988; 297: 1511\u20131512.","DOI":"10.1136\/bmj.297.6662.1511"},{"key":"c29","doi-asserted-by":"crossref","unstructured":"Oliver R.M: Bronchospasm and heroin inhalation. Lancet 1986; 1: 915.","DOI":"10.1016\/S0140-6736(86)91018-4"},{"key":"c30","doi-asserted-by":"crossref","unstructured":"Withington DE, Patrick JA, Reynolds F: Histamine release by morphine and diamorphine in man. Anaesthesia 1993; 48: p. 26\u201329.","DOI":"10.1111\/j.1365-2044.1993.tb06785.x"},{"key":"c31","unstructured":"Brashear R.E, Kelly M.T, White A.C: Elevated plasma histamine after heroin and morphine. J Lab Clin Med 1974; 83: 451\u2013457."},{"key":"c32","doi-asserted-by":"crossref","unstructured":"Buster M, et al.: Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend 2002; 68: 221\u2013228.","DOI":"10.1016\/S0376-8716(02)00193-X"},{"key":"c33","doi-asserted-by":"crossref","unstructured":"Walker PP, et al.: The Association Between Heroin Inhalation and Early Onset Emphysema. Chest 2015; 148: 1156\u20131163.","DOI":"10.1378\/chest.15-0236"},{"key":"c34","doi-asserted-by":"crossref","unstructured":"Megarbane B, Chevillard L: The large spectrum of pulmonary complications following illicit drug use: features and mechanisms. Chem Biol Interact 2013; 206: 444\u2013451.","DOI":"10.1016\/j.cbi.2013.10.011"},{"key":"c35","doi-asserted-by":"crossref","unstructured":"Wolters EC, et al.: Leucoencephalopathy after inhaling \u2019heroin\u2019 pyrolysate. Lancet 1982; 2: 1233\u20131237.","DOI":"10.1016\/S0140-6736(82)90101-5"},{"key":"c36","doi-asserted-by":"crossref","unstructured":"Kriegstein AR, Armitage BA, Kim PY: Heroin inhalation and progressive spongiform leukoencephalopathy. N Engl J Med 1997; 336: 589\u2013590.","DOI":"10.1056\/NEJM199702203360818"},{"key":"c37","doi-asserted-by":"crossref","unstructured":"Gossop M, et al.: The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607\u2013614.","DOI":"10.1046\/j.1360-0443.1995.9056072.x"},{"key":"c38","doi-asserted-by":"crossref","unstructured":"Strang J, et al.: Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict 1999; 8: 148\u2013160.","DOI":"10.1080\/105504999305956"},{"key":"c39","doi-asserted-by":"crossref","unstructured":"Diaper AM, Law FD, Melichar JK: Pharmacological strategies for detoxification. Br J Clin Pharmacol 2014; 77: 302\u2013314.","DOI":"10.1111\/bcp.12245"},{"key":"c40","doi-asserted-by":"crossref","unstructured":"Amato L, et al.: Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev 2013: CD003409.","DOI":"10.1002\/14651858.CD003409.pub4"},{"key":"c41","unstructured":"National Institute on Drug Abuse: What are the treatments for heroin use disorder?Bethesda; NIH: 2018. https:\/\/www.drugabuse.gov\/publications\/research-reports\/heroin\/what-are-treatments-heroin-use-disorder; letzter Zugriff: 25.09.2018."},{"key":"c42","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: European Drug Report. New heroin-assisted treatment. 2012. http:\/\/www.emcdda.europa.eu\/publications\/insights\/heroin-assisted-treatment_en; letzter Zugriff: 25.09.2018."}],"container-title":["Praxis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/1661-8157\/a003128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T09:18:06Z","timestamp":1615972686000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/1661-8157\/a003128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1024\/1661-8157\/a003128"],"URL":"https:\/\/doi.org\/10.1024\/1661-8157\/a003128","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}